We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · June 03, 2021

Anti–Neutrophil Cytoplasmic Antibody–Associated Glomerulonephritis Complicating Treatment With Hydralazine

Kidney International

 

Additional Info

Kidney International
Anti-Neutrophil Cytoplasmic Antibody Associated Glomerulonephritis Complicating Treatment With Hydralazine
Kidney Int. 2021 Apr 20;[EPub Ahead of Print], D Santoriello, AS Bomback, S Kudose, I Batal, MB Stokes, PA Canetta, J Radhakrishnan, GB Appel, VD D'Agati, GS Markowitz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading